CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.46M |
| 3 |
Gilead Sciences
GILD
|
$6.38M |
| 4 |
Amgen
AMGN
|
$6.24M |
| 5 |
Adobe
ADBE
|
$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.18M |
| 2 |
Analog Devices
ADI
|
$3.75M |
| 3 |
Amazon
AMZN
|
$3.48M |
| 4 |
lululemon athletica
LULU
|
$3.4M |
| 5 |
iQIYI
IQ
|
$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Domino's
DPZ
$15.7B
| $778K | 0.15% |
+1,888
| New | +$778K |
|
127
Crocs
CROX
$4.72B
| $726K | 0.14% |
7,775
| – | – |
|
128
Immunovant
IMVT
$2.99B
| $705K | 0.14% |
16,734
+13,374
| +398% | +$563K |
|
129
iShares Silver Trust
SLV
$20.1B
| $653K | 0.13% |
30,000
| – | – |
|
|
BPMC
130
DELISTED
Blueprint Medicines
BPMC
| $649K | 0.13% |
7,032
+5,482
| +354% | +$506K |
|
131
Skechers
SKX
$9.5B
| $647K | 0.13% |
10,374
+5,797
| +127% | +$361K |
|
132
iShares Gold Trust Micro
IAUM
$3.62B
| $639K | 0.12% |
31,000
+5,000
| +19% | +$103K |
|
133
Alphabet (Google) Class C
GOOG
$2.84T
| $620K | 0.12% |
4,401
-5,678
| -56% | -$800K |
|
134
Tyson Foods
TSN
$20B
| $610K | 0.12% |
+11,344
| New | +$610K |
|
135
Acadia Pharmaceuticals
ACAD
$4.26B
| $594K | 0.12% |
18,985
+14,783
| +352% | +$463K |
|
136
CRISPR Therapeutics
CRSP
$4.99B
| $575K | 0.11% |
9,193
+7,152
| +350% | +$448K |
|
137
ON Semiconductor
ON
$20.1B
| $573K | 0.11% |
6,856
-752
| -10% | -$62.8K |
|
138
Hilton Worldwide
HLT
$64B
| $568K | 0.11% |
3,122
| – | – |
|
139
Legend Biotech
LEGN
$6.66B
| $555K | 0.11% |
9,222
+7,174
| +350% | +$432K |
|
140
Carnival Corp
CCL
$42.8B
| $547K | 0.11% |
+29,500
| New | +$547K |
|
141
Revolution Medicines
RVMD
$7.57B
| $543K | 0.11% |
18,941
+16,139
| +576% | +$463K |
|
142
Alkermes
ALKS
$4.94B
| $536K | 0.1% |
19,306
+15,035
| +352% | +$417K |
|
143
Madrigal Pharmaceuticals
MDGL
$9.65B
| $530K | 0.1% |
2,292
+1,824
| +390% | +$422K |
|
144
Atour Lifestyle Holdings
ATAT
$5.39B
| $515K | 0.1% |
29,667
+2,500
| +9% | +$43.4K |
|
145
Insmed
INSM
$30.7B
| $513K | 0.1% |
16,551
+12,853
| +348% | +$398K |
|
146
ProShares Ultra Gold
UGL
$618M
| $511K | 0.1% |
+32,000
| New | +$511K |
|
147
Expedia Group
EXPE
$26.6B
| $505K | 0.1% |
3,330
| – | – |
|
148
Nuvalent
NUVL
$5.83B
| $487K | 0.09% |
6,619
+5,292
| +399% | +$389K |
|
149
Amicus Therapeutics
FOLD
$2.46B
| $481K | 0.09% |
33,920
+26,552
| +360% | +$377K |
|
|
MRTX
150
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $477K | 0.09% |
8,117
+6,365
| +363% | +$374K |
|